Page 125 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GESMD
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
Mosquera Orgueira A, Pérez Encinas M, Díaz Varela NA, Mora E, Díaz-Beyá M, Monto- ro MJ, Pomares H, Ramos F, Tormo M, Jerez A, Nomdedéu JF, De Miguel Sánchez C, Arenillas L, Cárcel P, Cedena Romero MT, Xicoy B, Rivero E, del Orbe Barreto RA, Díez- Campelo M, Benlloch LE, Crucitti D, Valcárcel D .
• Evaluation of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent Low Risk Del(5q) MDS Patients. Final Results of Sintra-REV Phase III International Multi- center Clinical Trial.
64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Orle- ans (USA), 10-13 de diciembre de 2022.
López Cadenas F, Lumbreras E, González T, Xicoy B, Sánchez-García J, Coll R, Slama B, Hernández-Rivas JA, Thepot S, Bernal T, Guerci-Bresler A, Sanz G, Bargay J, Amigo ML, De Paz Arias R, Preudhomme C, Giagounidis A, Platzbecker U, Wickenhauser S, Goet- ze KS, Arar A, Hernández-Rivas JM, Toribio Castelló SM, Fenaux P, Del Cañizo C, Díez- Campelo M .
• Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes.
64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Orle- ans (USA), 10-13 de diciembre de 2022.
Sauta E, Robin M, Bersanelli M, Travaglino E, Meggendorfer M, Zhao LP, Caballero-Berro- cal JC, Maggioni G, Tentori CA, Bernardi M, Di Grazia C, Vago L, Rivoli G, Borin L, D’Amico S, Ubezio M, Campagna A, Russo A, Mannina D, Lanino L, Chiusolo P, Giaccone L, Voso MT, Riva M, Oliva E, Zampini M, Riva E, Nibourel O, Sala C, Bicchieri M, Bolli N, Rambaldi A, Passamonti F, Savevski V, Santoro A, Germing U, Kordasti S, Santini V, Díez-Campelo M, Sanz G, Solé F, Kern W, Platzbecker U, Ades L, Fenaux P, Haferlach T, Castellani G, Della Porta MG .
• Recommendations of the International Working Group for Clinical Implementation of Optical Genome Mapping in Hematologic Malignancies.
Cancer Genomics Consortium (CGC) 13th Annual Meeting. St. Louis, MO, July 31-August 3, 2022.
Smith AC, Kanagal-Shamanna R, Dewaele B, Rack K, Hoischen A, Neveling K, Raca G, Levy B, Kolhe R, Espinet B, Puiggrós A, Solé F, Mallo M .
• Treatment Patterns and Overall Survival in Patients with Intermediate-Risk Myelo- dysplastic Syndrome (MDS): A Retrospective Analysis in the Grupo Español de Sín- dromes Mielodisplásicos (GESMD) Spanish MDS Registry.
International Myelodysplastic Syndromes (MDS) Meeting 2022.
125